Author:
O’Mara Megan L.,Deplazes Evelyne
Reference26 articles.
1. Alder BJ, Wainwright TE (1959) Studies in molecular dynamics. I. General method. J Chem Phys 31:459–466
2. Baron R, Nichols SE, McCammon JA (2012) On the use of molecular dynamics receptor conformations for virtual screening. In: Baron R (ed) Computational drug discovery and design. Springer, New York
3. Cross AJ, Yocca FD (2012) Essential CNS drug development – pre-clinical development. In: Kalali A, Preskorn S, Kwentus J, Stahl SM (eds) Essential CNS drug development. Cambridge University Press, Cambridge
4. De Lucca GV, Erickson-Viitanen S, Lam PYS (1997) Cyclic HIV protease inhibitors capable of displacing the active site structural water molecule. Drug Discov Today 2:6–18
5. Druker BJ, Lydon NB (2000) Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J Clin Investig 105:3–7